BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 20096431)

  • 1. Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?
    Hori T; Uemoto S; Takada Y; Oike F; Ogura Y; Ogawa K; Miyagawa-Hayashino A; Yurugi K; Nguyen JH; Hori Y; Chen F; Egawa H
    Surgery; 2010 Jun; 147(6):840-4. PubMed ID: 20096431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult living-donor liver transplantation with ABO-incompatible grafts.
    Testa G; Vidanovic V; Chejfec G; Gangemi A; Iqpal R; Porubsky M; Pham T; Benedetti E
    Transplantation; 2008 Mar; 85(5):681-6. PubMed ID: 18337660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of positive cytotoxic cross-match in adult-to-adult living donor liver transplantation using small graft volume.
    Suh KS; Kim SB; Chang SH; Kim SH; Minn KW; Park MH; Han KS; Lee KU
    Liver Transpl; 2002 Dec; 8(12):1109-13. PubMed ID: 12474148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual living donor liver transplantation with ABO-incompatible and ABO-compatible grafts to overcome small-for-size graft and ABO blood group barrier.
    Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Kwon SW; Ko GY; Kim KW
    Liver Transpl; 2010 Apr; 16(4):491-8. PubMed ID: 20222051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exchange living donor liver transplantation to overcome ABO incompatibility in adult patients.
    Hwang S; Lee SG; Moon DB; Song GW; Ahn CS; Kim KH; Ha TY; Jung DH; Kim KW; Choi NK; Park GC; Yu YD; Choi YI; Park PJ; Ha HS
    Liver Transpl; 2010 Apr; 16(4):482-90. PubMed ID: 20222052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HLA-identity on results of ABO-incompatible living kidney transplantation.
    Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Teraoka S; Toma H
    Transplant Proc; 2004 Sep; 36(7):2172-4. PubMed ID: 15518790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation.
    Ushigome H; Okamoto M; Koshino K; Nobori S; Okajima H; Masuzawa N; Urasaki K; Yoshimura N
    Clin Transplant; 2010 Jul; 24 Suppl 22():16-21. PubMed ID: 20590688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult ABO-incompatible liver transplantation, using A and B donors.
    Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L
    Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidonor antibody in patients receiving ABO-identical and HLA-mismatched living donor liver transplants: effect on survival.
    Ashihara E; Tsuji H; Sakashita H; Haga H; Yurugi K; Kimura S; Egawa H; Manabe T; Uemoto S; Maekawa T
    Transplantation; 2007 Feb; 83(4):506-9. PubMed ID: 17318084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
    Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
    Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
    Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
    Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present status of ABO-incompatible kidney transplantation in Japan.
    Takahashi K; Saito K
    Xenotransplantation; 2006 Mar; 13(2):118-22. PubMed ID: 16623804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
    Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eight years of outcomes of the Dutch Living Donor Kidney Exchange Program.
    de Klerk M; Kal-van Gestel JA; Haase-Kromwijk BJ; Claas FH; Weimar W;
    Clin Transpl; 2011; ():287-90. PubMed ID: 22755421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen compatibility and lymphocyte cross-matching play no significant role in the current adult-to-adult living donor liver transplantation.
    Badawy A; Kaido T; Yoshizawa A; Yagi S; Fukumitsu K; Okajima H; Uemoto S
    Clin Transplant; 2018 Apr; 32(4):e13234. PubMed ID: 29499077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
    Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
    Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.
    Egawa H; Ohmori K; Haga H; Tsuji H; Yurugi K; Miyagawa-Hayashino A; Oike F; Fukuda A; Yoshizawa J; Takada Y; Tanaka K; Maekawa T; Ozawa K; Uemoto S
    Liver Transpl; 2007 Apr; 13(4):579-88. PubMed ID: 17394164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.